Market Research Report - 234009
Global Biosimilars Market Forecast to 2015
|Published by||RNCOS E-Services Pvt. Ltd.|
|Published||Content info||140 Pages|
The biosimilars industry has been growing stupendously across the globe for past few years. Increasing healthcare costs and rising aging population are driving the industry, which stands at a vivid position and is expected to evolve greatly from its current state. As per the estimations of our latest report, the global biosimilars market will grow at a CAGR of around 52% during 2010-2015. With the governments and private players worldwide stepping in the industry, the market shows bright prospects and immense opportunities to cash in on.
According to “Global Biosimilars Market Forecast to 2015”, the first-generation biosimilars currently dominate the market, and their second-generation is expected to grow stupendously in the future. Our report provides a thorough study of the biosimilars market, and its segmentation at the product and country level. We have carried out a detailed market-segmentation analysis in the study, which presents forecasts on the first-generation biosimilars. Key developments in each segment have also been highlighted in it to tell ‘what is going on' in the market.
For key regulated and unregulated markets including the US, Europe, India, China and Korea, the geographic-segmentation has been included. Our research has studied the overall industry performance and key biosimilar products in the market, and found that patent expirations offer a huge potential to new market entrants. The recent industry activities have been tracked, and the regulatory scenario has been analyzed to provide an impartial picture of the industry to clients.
We have covered the key market players in different geographies, and provided in the report a look at their activities, recent developments and key biosimilar products. We observed that players such as Sandoz/Novartis AG, Hospira and Teva are the global market leaders. Overall, the report aims at providing complete information about the biosimilar industry to clients who are planning to enter the biosimilars market.